-
KAUSKAS-100
Epilepsy Adults and adolescents aged 13 years and above - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - Seizures… -
KAUSKAS-200
Epilepsy Adults and adolescents aged 13 years and above - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - Seizures… -
KAUSKAS-50
Epilepsy Adults and adolescents aged 13 years and above - Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. - Seizures… -
KEIKAI
Monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over. This is only… -
LAKCAY
Raloxifen is indicated for the treatment and prevention of osteoporosis in postmenopausal women. A significant reduction in the incidence of vertebral, but not hip fractures… -
LEVETRAL
Monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed… -
LEVETRAL-750
Monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed… -
MAGRAX
Treatment of rheumatoid arthritis (RA), inflammation associated with acute gouty arthritis, ankylosing spondylitis in adults and adolescents 16 years of age and older. Treatment of… -
MAGRAX-F
Acute gouty arthritis This is only the preview. Please check here for the full indication. -
MALAG-60
Fexofenadine is indicated in adults and children 6 years and older for the relief of symptoms associated with seasonal allergic rhinitis. This is only the… -
MANZURA-15
Treatment of schizophrenia. Maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Treatment of moderate to severe manic…